The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apatinib plus paclitaxel versus placebo plus paclitaxel as second-line therapy in patients with gastric cancer with peritoneal carcinomatosis: A double-blind, randomized phase II trial.
 
Fenghua Wang
No Relationships to Disclose
 
Chao Ren
No Relationships to Disclose
 
Jianying Xu
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Ming-ming He
No Relationships to Disclose
 
Miaozhen Qiu
No Relationships to Disclose
 
Ying Jin
No Relationships to Disclose
 
Huiyan Luo
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Yuhong Li
No Relationships to Disclose
 
Qiong Tan
No Relationships to Disclose
 
Rong Zhang
No Relationships to Disclose
 
Ruihua Xu
No Relationships to Disclose